These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 3470296

  • 21. Synergistic effect of IL-4 and TNF-alpha in the induction of monocytic differentiation of a mouse myeloid leukaemic cell line (WEHI-3B JCS).
    Leung KN, Mak NK, Fung MC, Hapel AJ.
    Immunology; 1994 Jan; 81(1):65-72. PubMed ID: 8132222
    [Abstract] [Full Text] [Related]

  • 22. Biological effects of recombinant human tumor necrosis factor and its novel muteins on tumor and normal cell lines.
    Creasey AA, Doyle LV, Reynolds MT, Jung T, Lin LS, Vitt CR.
    Cancer Res; 1987 Jan 01; 47(1):145-9. PubMed ID: 3791201
    [Abstract] [Full Text] [Related]

  • 23. Role of tumor necrosis factor alpha in hyperthermia-induced apoptosis of human leukemia cells.
    Katschinski DM, Robins HI, Schad M, Frede S, Fandrey J.
    Cancer Res; 1999 Jul 15; 59(14):3404-10. PubMed ID: 10416602
    [Abstract] [Full Text] [Related]

  • 24. Cell cycle events associated with the termination of proliferation by cytotoxic and differentiation-inducing actions of 6-thioguanine on HL-60 cells.
    Schwartz EL, Blair OC, Sartorelli AC.
    Cancer Res; 1984 Sep 15; 44(9):3907-10. PubMed ID: 6589046
    [Abstract] [Full Text] [Related]

  • 25. Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin.
    Kornbluth RS, Edgington TS.
    J Immunol; 1986 Oct 15; 137(8):2585-91. PubMed ID: 3760568
    [Abstract] [Full Text] [Related]

  • 26. Cytostatic and cytolytic effects of human recombinant tumor necrosis factor on human renal cell carcinoma cell lines derived from a single surgical specimen.
    Heicappell R, Naito S, Ichinose Y, Creasey AA, Lin LS, Fidler IJ.
    J Immunol; 1987 Mar 01; 138(5):1634-40. PubMed ID: 3805727
    [Abstract] [Full Text] [Related]

  • 27. Evidence for cell cycle phase-specific initiation of a program of HL-60 cell myeloid differentiation mediated by inducer uptake.
    Yen A, Albright KL.
    Cancer Res; 1984 Jun 01; 44(6):2511-5. PubMed ID: 6327017
    [Abstract] [Full Text] [Related]

  • 28. Synergistic enhancement by tumor necrosis factor of in vitro cytotoxicity from chemotherapeutic drugs targeted at DNA topoisomerase II.
    Alexander RB, Nelson WG, Coffey DS.
    Cancer Res; 1987 May 01; 47(9):2403-6. PubMed ID: 2436763
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. IL-4 and TNF-alpha-mediated proliferation of the human megakaryocytic line M-O7E is regulated by induced autocrine production of GM-CSF.
    Wadhwa M, Dilger P, Meager A, Walker B, Gaines-Das R, Thorpe R.
    Cytokine; 1996 Dec 01; 8(12):900-9. PubMed ID: 9050748
    [Abstract] [Full Text] [Related]

  • 33. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and actinomycin D induces apoptosis even in TRAIL-resistant human pancreatic cancer cells.
    Matsuzaki H, Schmied BM, Ulrich A, Standop J, Schneider MB, Batra SK, Picha KS, Pour PM.
    Clin Cancer Res; 2001 Feb 01; 7(2):407-14. PubMed ID: 11234897
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cytostatic and cytotoxic activity of tumor necrosis factor on human cancer cells.
    Ruggiero V, Latham K, Baglioni C.
    J Immunol; 1987 Apr 15; 138(8):2711-7. PubMed ID: 3031163
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines.
    Kim DM, Koo SY, Jeon K, Kim MH, Lee J, Hong CY, Jeong S.
    Cancer Res; 2003 Feb 01; 63(3):621-6. PubMed ID: 12566305
    [Abstract] [Full Text] [Related]

  • 39. Differential role of diphenyleneiodonium, a flavoenzyme inhibitor, on p53-dependent and -independent cell cycle progression.
    Song JD, Kim KM, Kim KH, Kim CD, Kim JM, Yoo YH, Park YC.
    Int J Oncol; 2008 Dec 01; 33(6):1299-306. PubMed ID: 19020764
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.